These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9829633)

  • 61. A peptide mimotope of hepatitis C virus E2 protein is immunogenic in mice and block human anti-HCV sera.
    El-Attar LM; Partidos CD; Howard CR
    J Med Virol; 2010 Oct; 82(10):1655-65. PubMed ID: 20827761
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
    Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Establishment of hybrid cell lines producing monoclonal antibodies to a synthetic peptide from the E1 region of the hepatitis C virus.
    Tabll AA; Khalil SB; El-Shenawy RM; Esmat G; Helmy A; Attallah AF; El-Awady MK
    J Immunoassay Immunochem; 2008; 29(1):91-104. PubMed ID: 18080883
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
    Mancini N; Canducci F; Carletti S; Berardinelli E; Serafini G; Grieco A; Perotti M; Malcangi G; Danieli MG; Varaldo PE; Clementi M; Burioni R
    J Biol Regul Homeost Agents; 2003; 17(2):183-7. PubMed ID: 14518720
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid.
    Tordjeman M; Fontan G; Rabillon V; Martin J; Trepo C; Hoffenbach A; Mabrouk K; Sabatier JM; Van Rietschoten J; Somme G
    J Med Virol; 1993 Nov; 41(3):221-9. PubMed ID: 7505307
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection.
    Peterson J; Green G; Iida K; Caldwell B; Kerrison P; Bernich S; Aoyagi K; Lee SR
    Vox Sang; 2000; 78(2):80-5. PubMed ID: 10765142
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
    Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
    Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epitope analysis of an immunodominant domain on the P1 protein of Haemophilus influenzae type b using synthetic peptides and anti-idiotypic antibodies.
    Proulx C; Hamel J; Chong P; Martin D; Brodeur BR
    Microb Pathog; 1992 Jun; 12(6):433-42. PubMed ID: 1522798
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
    Falconar AK
    Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization.
    Hu GJ; Wang RY; Han DS; Alter HJ; Shih JW
    Vaccine; 1999 Aug; 17(23-24):3160-70. PubMed ID: 10462252
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations.
    Robinson JW; Rosas M; Guzman F; Patarroyo ME; Moreno A
    J Med Virol; 1996 Oct; 50(2):188-92. PubMed ID: 8915886
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody.
    Mondelli MU; Cerino A; Boender P; Oudshoorn P; Middeldorp J; Fipaldini C; La Monica N; Habets W
    J Virol; 1994 Aug; 68(8):4829-36. PubMed ID: 7518528
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mapping and characterization of B cell linear epitopes in the conservative regions of hepatitis C virus envelope glycoproteins.
    Olenina LV; Nikolaeva LI; Sobolev BN; Blokhina NP; Archakov AI; Kolesanova EF
    J Viral Hepat; 2002 May; 9(3):174-82. PubMed ID: 12010504
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees.
    Wang YF; Brotman B; Andrus L; Prince AM
    J Infect Dis; 1996 Apr; 173(4):808-21. PubMed ID: 8603958
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A highly sensitive and specific enzyme-linked immunosorbent assay of antibodies to hepatitis C virus.
    Eroglu C; Yildiz E; Ozturk M; Pinarbasi E
    Acta Virol; 2000 Feb; 44(1):29-33. PubMed ID: 10989689
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes.
    Gu J; Hardy J; Boo I; Vietheer P; McCaffrey K; Alhammad Y; Chopra A; Gaudieri S; Poumbourios P; Coulibaly F; Drummer HE
    J Virol; 2018 May; 92(9):. PubMed ID: 29467319
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient.
    Barban V; Fraysse-Corgier S; Paranhos-Baccala G; Petit M; Manin C; Berard Y; Prince AM; Mandrand B; Meulien P
    J Gen Virol; 2000 Feb; 81(Pt 2):461-9. PubMed ID: 10644845
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.
    Troesch M; Jalbert E; Canobio S; Boulassel MR; Routy JP; Bernard NF; Bruneau J; Lapointe N; Boucher M; Soudeyns H
    AIDS; 2005 May; 19(8):775-84. PubMed ID: 15867491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of antigenic determinants in the core antigen of the hepatitis C virus.
    Goeser T; Müller HM; Ye J; Pfaff E; Theilmann L
    Virology; 1994 Dec; 205(2):462-9. PubMed ID: 7526540
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A monoclonal inhibition enzyme immunoassay for detection of antibodies against hepatitis B core antigen: confirmation of an immunodominant epitope.
    Pujol FH; Bertolotti A; Fields HA; Khudyakov YE; Kalinina TI; Liprandi F
    J Immunoassay; 1994 Aug; 15(3):239-49. PubMed ID: 7929851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.